Boston Scientific · Operating Cash Flow (Statement)

Latest reported$4.53Bperiod endingJun 30, 2026

BSX Cash from Operations ($29.60M → $4.53B)

Annual operating cash flow (statement)

High-resolution chart · PNG

BSX operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Boston Scientific Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	4,534,000,000
Dec 31, 2024	3,435,000,000
Dec 31, 2023	2,503,000,000
Dec 31, 2022	1,526,000,000
Dec 31, 2021	1,871,000,000
Dec 31, 2020	1,508,000,000
Dec 31, 2019	1,836,000,000
Dec 31, 2018	310,000,000
Dec 31, 2017	1,426,000,000
Dec 31, 2016	972,000,000
Dec 31, 2015	600,000,000
Dec 31, 2014	1,269,000,000
Dec 31, 2013	1,082,000,000
Dec 31, 2012	1,260,000,000
Dec 31, 2011	1,008,000,000
Dec 31, 2010	325,000,000
Dec 31, 2009	835,000,000
Dec 31, 2008	1,216,000,000
Dec 31, 2007	934,000,000
Dec 31, 2006	1,845,000,000
Dec 31, 2005	903,000,000
Dec 31, 2004	1,804,000,000
Dec 31, 2003	787,000,000
Dec 31, 2002	736,000,000
Dec 31, 2001	490,000,000
Dec 31, 2000	739,000,000
Dec 31, 1999	727,000,000
Dec 31, 1998	258,500,000
Dec 31, 1997	80,500,000
Dec 31, 1996	134,300,000
Dec 31, 1995	25,000,000
Dec 31, 1994	67,800,000
Dec 31, 1993	65,800,000
Dec 31, 1992	42,500,000
Dec 31, 1991	29,600,000